rs9260100

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The ENST00000396634.5(HLA-A):​c.-281-201A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 151,258 control chromosomes in the GnomAD database, including 496 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 496 hom., cov: 34)

Consequence

HLA-A
ENST00000396634.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.500

Publications

2 publications found
Variant links:
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]
HCG4P5 (HGNC:22925): (HLA complex group 4 pseudogene 5)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000396634.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000396634.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-A
ENST00000396634.5
TSL:6
c.-281-201A>G
intron
N/AENSP00000379873.1P04439-1
POLR1HASP
ENST00000849679.1
n.66-13219T>C
intron
N/A
POLR1HASP
ENST00000849682.1
n.751-13219T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.129
AC:
19565
AN:
151138
Hom.:
492
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.171
Gnomad AMI
AF:
0.102
Gnomad AMR
AF:
0.143
Gnomad ASJ
AF:
0.128
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.0890
Gnomad MID
AF:
0.143
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.144
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.130
AC:
19613
AN:
151258
Hom.:
496
Cov.:
34
AF XY:
0.129
AC XY:
9575
AN XY:
73970
show subpopulations
African (AFR)
AF:
0.171
AC:
7014
AN:
41022
American (AMR)
AF:
0.144
AC:
2184
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
442
AN:
3454
East Asian (EAS)
AF:
0.122
AC:
625
AN:
5120
South Asian (SAS)
AF:
0.163
AC:
777
AN:
4762
European-Finnish (FIN)
AF:
0.0890
AC:
942
AN:
10584
Middle Eastern (MID)
AF:
0.147
AC:
43
AN:
292
European-Non Finnish (NFE)
AF:
0.106
AC:
7193
AN:
67816
Other (OTH)
AF:
0.143
AC:
300
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.427
Heterozygous variant carriers
0
606
1212
1818
2424
3030
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.115
Hom.:
48

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.9
DANN
Benign
0.74
PhyloP100
-0.50
PromoterAI
-0.013
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.36
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.36
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs9260100;
hg19: chr6-29909542;
COSMIC: COSV65139499;
COSMIC: COSV65139499;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.